BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2539818)

  • 1. Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats.
    Keyler DE; Pentel PR
    Biochem Pharmacol; 1989 Apr; 38(7):1163-8. PubMed ID: 2539818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
    Pentel PR; Keyler DE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of serum, alpha-1 acid glycoprotein, lipoproteins and albumin on human mononuclear leucocyte beta-adrenoceptors.
    Sager G; Sandnes D; Aakesson I; Jacobsen S
    Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):193-203. PubMed ID: 3012942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.
    Yasuhara M; Fujiwara J; Kitade S; Katayama H; Okumura K; Hori R
    J Pharmacol Exp Ther; 1985 Nov; 235(2):513-20. PubMed ID: 2997437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderly.
    Tenero DM; Bottorff MB; Burlew BS; Williams JB; Lalonde RL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):702-7. PubMed ID: 1703590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
    Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
    Murai-Kushiya M; Okada S; Kimura T; Hasegawa R
    J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alpha 1-acidglycoprotein on myocardial uptake and pharmacodynamics of quinidine in perfused rat heart.
    Huang JL; Morgan DJ
    Biochem Pharmacol; 1993 Nov; 46(10):1705-11. PubMed ID: 8250956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence studies of beta-adrenergic ligand binding to alpha 1-acid glycoprotein with 1-anilino-8-naphthalene sulfonate, isoprenaline, adrenaline and propranolol.
    Johansen AK; Willassen NP; Sager G
    Biochem Pharmacol; 1992 Feb; 43(4):725-9. PubMed ID: 1540225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol disposition in the rat: variation in hepatic extraction with unbound drug fraction.
    Gariépy L; Fenyves D; Villeneuve JP
    J Pharm Sci; 1992 Mar; 81(3):255-8. PubMed ID: 1640364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of furosemide on plasma concentration and beta-blockade by propranolol.
    Chiariello M; Volpe M; Rengo F; Trimarco B; Violini R; Ricciardelli B; Condorelli M
    Clin Pharmacol Ther; 1979 Oct; 26(4):433-6. PubMed ID: 226305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of catecholamines to alpha-1 acid glycoprotein, albumin and lipoproteins in human serum.
    Sager G; Bratlid H; Little C
    Biochem Pharmacol; 1987 Nov; 36(21):3607-12. PubMed ID: 3675618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and toxicity of high-dose human alpha 1-acid glycoprotein infusion in the rat.
    Keyler DE; Pentel PR; Haughey DB
    J Pharm Sci; 1987 Feb; 76(2):101-4. PubMed ID: 3572744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
    Belpaire FM; Bogaert MG; Mugabo P; Rosseel MT
    Br J Pharmacol; 1986 Jul; 88(3):697-705. PubMed ID: 2874859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG).
    McNamara PJ; Brouwer KR; Gillespie MN
    Biochem Pharmacol; 1986 Feb; 35(4):621-4. PubMed ID: 3947392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the sialylation state of alpha 1-acid glycoprotein on propranolol binding.
    Primozic S; McNamara PJ
    J Pharm Sci; 1985 Apr; 74(4):473-5. PubMed ID: 3999012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
    Clements JD; Jamali F
    Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
    Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
    Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
    Steinkraus V; Nose M; Scholz H; Thormählen K
    Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
    van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
    J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.